Cover Image


Point-of-Care Drug Reconstitution Systems to 2020

出版商 Greystone Research Associates 商品編碼 228359
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
Back to Top
重點照護藥劑再調製:治療市場、技術、策略、展望 Point-of-Care Drug Reconstitution Systems to 2020
出版日期: 2014年01月13日 內容資訊: 英文


第1章 報告摘要

第2章 市場動態

  • 延長生物醫藥品的有效期限
    • 銷售策略
    • 製劑策略
  • 凍結乾燥與使用時的再調製
  • 醫療經濟學與再調製系統
  • 工學再調製系統的成長促進因子
    • 生物醫藥品的普及
    • 自我投藥的動向
    • 人口統計的變化
    • 拋棄式裝置設計的創新
  • 治療需求促進因子
  • 競爭狀況
  • 風險因子

第3章 藥劑再調製系統:商業性裝置

  • Vial Adapter
  • Vial-to-Vial系統
  • 無針式移動裝置
  • Vial的直接連結
  • 藥袋的直接連結
  • 雙腔式注射器
  • 雙腔式藥袋
  • 封閉式藥物處理

第4章 再調製系統的設計因子

  • 安定性與材料選定的問題
  • 拋棄式藥劑包
  • 單次/複數投藥裝置
  • 人體工學/人類工程學

第5章 藥物重組:治療領域分析

第6章 市場因素

第7章 企業簡介


Product Code: DRP222F

Growth in the number of injectable drugs supplied in solid form for reconstitution prior to administration is being driven by the increase in drugs based on biological NCEs. These drugs are typically unstable at ambient temperatures and to preserve their shelf life must be either stored at low temperature (the so-call 'cold chain') or processed into a form that will preserve their pharmacological efficacy until they reach their therapeutic destination. Because the cost of transporting and storing drugs using refrigeration is expensive and requires constant temperature monitoring to insure that the drug has not been exposed to environmental conditions that render unsafe for use as a therapeutic product, technologies such as lyophilization are becoming more prevalent. The packaging and technologies developed and marketed for safe and reliable reconstitution at the point of administration are benefiting from this market trend. This report examines commercial drug reconstitution devices and systems and their impact on the injectable drug delivery sector.


  • Analyzes therapeutic demand drivers and evaluates the market impact and potential of commercial drug reconstitution systems
  • Provides analysis of injectable drugs for reconstitution and assesses key market segments, market dynamics and market demographics
  • Forecasts Injectable drug product demand by indication and therapy to 2020
  • Profiles reconstitution system suppliers, their product activities, business strategies, and corporate alliances and affiliations

Table of Contents

Executive Summary

  • Market Dynamics
  • Prolonging the Shelf Life of Biological Drugs
  • Distribution Strategies
  • Formulation Strategies
  • Lyophilization and Reconstitution at the Point of Use
  • Healthcare Economics and Reconstitution Systems
  • What's Driving the Growth in Engineered Reconstitution Systems?
  • Biological Drugs Proliferating
  • The Trend toward Self-Administration
  • Shifting Demographics
  • Innovation in Disposable Device Designs
  • Therapeutic Demand Drivers
  • Competitive Landscape
  • Risk Factors
  • Drug Reconstitution Systems - Commercial Devices
  • Vial Adapters
  • Vial-to-Vial Systems
  • Needle-less Transfer Devices
  • Direct Connect to Vial
  • Direct Connect to Cartridge
  • Dual Chamber Syringes
  • Dual Chamber Cartridges
  • Closed Drug Transfer
  • Reconstitution System Design Factors
  • Stability and Material Selection Issues
  • Disposable Drug Cartridges
  • Single vs Multi-Dose Devices
  • Human Engineering/Ergonomics

Drug Reconstitution - Therapeutic Sector Analysis

Market Factors

Drug Reconstitution Systems - Company Profiles

Back to Top